DPP4 expression levels also correlate with tumor aggressiveness and invasiveness, and have been confirmed in various tumors, including renal cell carcinoma, melanoma, gynecological cancer, and hematological malignancy [29, 30]. This evidence concerns the gene DPP4 and melanoma.